🇮🇳IN
Sign In
GL

GLENMARK

NSE

Glenmark Pharmaceuticals Limited

₹2,408.00

+26.00(+1.09%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into GLENMARK. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

GLENMARK exposure summary

Glenmark Pharmaceuticals Limited reports a single business segment, Pharmaceuticals. Glenmark Pharmaceuticals Limited is a constituent of 9 indices, with its largest weights in NIFTY Pharma (3.57%), NIFTY Healthcare Index (3.05%), NIFTY Midcap 50 (1.57%). 25 exchange-traded funds hold the stock.

Index memberships9
ETFs holding25

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer